Skip to main content

Knee Pain

0
Pipeline Programs
3
Companies
4
Clinical Trials
0
Approved Products

Pipeline by Development Stage

Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
0
0
0
0
0
0
Early DiscoveryClinical DevelopmentMarket

Competitive Landscape

2 companies ranked by most advanced pipeline stage

Zimmer Biomet
Zimmer BiometFL - Jacksonville
3 programs
Device: Persona Total KneeN/A1 trial
PERSONA Total KneeN/A1 trial
PERSONA Total KneeN/A1 trial
Active Trials
NCT04338893Completed252Est. Aug 2025
NCT03969654Completed181Est. Sep 2023
NCT03970629Terminated19Est. Nov 2021
Omron Healthcare
Omron HealthcareJapan - Kyoto
1 program
electrical stimulationN/A1 trial
Active Trials
NCT04084236Unknown30Est. May 2020

Trial Timeline

Clinical trial activity over time

2021
2022
2023
2024
2025
2026
Zimmer BiometDevice: Persona Total Knee
Zimmer BiometPERSONA Total Knee
Omron Healthcareelectrical stimulation
Zimmer BiometPERSONA Total Knee

Clinical Trials (4)

Total enrollment: 482 patients across 4 trials

NCT04338893Zimmer BiometDevice: Persona Total Knee

ROSA Total Knee Post Market Study EMEA

Start: Dec 2020Est. completion: Aug 2025252 patients
N/ACompleted
NCT03969654Zimmer BiometPERSONA Total Knee

ROSA Robot Used in Total Knee Replacement Post Market Study

Start: May 2020Est. completion: Sep 2023181 patients
N/ACompleted
NCT04084236Omron Healthcareelectrical stimulation

The Effects of Transcutaneous Electrical Nerve Stimulation on People With Knee Osteoarthritis (OA) and or Chronic Pain

Start: Jul 2019Est. completion: May 202030 patients
N/AUnknown
NCT03970629Zimmer BiometPERSONA Total Knee

ROSA Total Knee Investigational Testing Authorization Study

Start: Jun 2019Est. completion: Nov 202119 patients
N/ATerminated

Phase Legend

PreclinicalLab & animal studies
Phase 1Safety & dosing
Phase 2Efficacy testing
Phase 3Large-scale trials
On MarketApproved & available

Key Insights

3 companies competing in this space

The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.